ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,849Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 324

$1.12M Total Retail Price of All Prescriptions

Rank: 10 out of 324

737 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 737 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 18,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 1,159 1,002 1 1
LEVOTHYROXINE SODIUM 1,106 923 2 2
LISINOPRIL 1,034 862 3 3
AMLODIPINE BESYLATE 847 763 4 4
FUROSEMIDE 609 526 5 7
OMEPRAZOLE 575 517 6 6
SERTRALINE HCL 555 489 7 23
ATENOLOL 525 457 8 18
LOSARTAN POTASSIUM 474 438 9 15
METFORMIN HCL 466 363 10 9
POTASSIUM CHLORIDE 444 396 11 8
HYDROCHLOROTHIAZIDE 399 360 12 11
WARFARIN SODIUM 380 320 13 10
ATORVASTATIN CALCIUM 355 304 14 12
HYDROCODONE-ACETAMINOPHEN 353 257 S3 15 5
GABAPENTIN 341 278 16 13
PANTOPRAZOLE SODIUM 324 250 17 34
CYMBALTA 275 235 18 45
METOPROLOL TARTRATE 273 215 19 14
LANTUS 270 209 20 39
ZOLPIDEM TARTRATE 268 198 21 20
METOPROLOL SUCCINATE 228 201 22 17
CITALOPRAM HBR 216 147 23 16
NOVOLOG 211 157 24 60
AZITHROMYCIN 210 168 25 48
TRAMADOL HCL 206 160 26 19
FELODIPINE ER 201 201 27 158
DONEPEZIL HCL 196 184 28 25
TAMSULOSIN HCL 192 172 29 26
RANITIDINE HCL 189 128 30 58
LANTUS SOLOSTAR 178 125 31 85
ALLOPURINOL 173 165 32 27
ZETIA 154 130 33 68
LEVOFLOXACIN 150 133 34 84
NEXIUM 148 143 35 33
FLUTICASONE PROPIONATE 145 113 36 32
ESCITALOPRAM OXALATE 144 114 37 54
HUMALOG 142 119 38 103
MELOXICAM 141 119 39 29
ALENDRONATE SODIUM 129 127 40 24
AMITRIPTYLINE HCL 128 119 R 41 66
CLOPIDOGREL 121 91 42 38
GLYBURIDE 115 94 R 43 59
METHYLPREDNISOLONE 113 89 44 171
LYRICA 108 103 45 107
PEN NEEDLE 108 71 45 146
PLAVIX 107 90 47 63
TRICOR 99 64 48 126
ZOSTAVAX 95 84 49 138
KLOR-CON M20 94 68 50 52
AMOX TR-POTASSIUM CLAVULANATE 91 71 51 153
CLONIDINE HCL 90 78 52 53
PRAVASTATIN SODIUM 89 86 53 21
ESTRADIOL 86 76 R 54 98
FINASTERIDE 82 81 55 101
SYNTHROID 82 82 55 30
CYCLOBENZAPRINE HCL 82 50 R 55 51
ENALAPRIL MALEATE 82 80 55 57
MIRTAZAPINE 82 78 55 41
DIOVAN 82 54 55 56
CLOTRIMAZOLE-BETAMETHASONE 82 66 55 182
OXYBUTYNIN CHLORIDE 81 66 62 88
TRAZODONE HCL 80 33 63 42
PREDNISONE 79 73 64 36
FLUOXETINE HCL 74 34 65 67
LOVASTATIN 72 71 66 43
LOSARTAN-HYDROCHLOROTHIAZIDE 71 71 67 44
CARVEDILOL 70 65 68 22
NOVOLOG FLEXPEN 64 33 69 112
IPRATROPIUM-ALBUTEROL 64 61 69 118
KLOR-CON M10 63 63 71 117
LEXAPRO 62 55 72 219
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 45 72 35
LIPITOR 61 36 74 109
ISOSORBIDE MONONITRATE ER 61 49 74 65
VENLAFAXINE HCL ER 61 49 74 86
FENOFIBRATE 61 46 74 79
CRESTOR 59 57 78 28
VESICARE 58 58 79 166
GLIMEPIRIDE 54 54 80 37
PROAIR HFA 54 42 80 50
CELEBREX 53 37 82 96
AMIODARONE HCL 52 50 83 151
CEPHALEXIN 52 41 83 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.